Unknown PHASE1/PHASE2 INTERVENTIONAL NCT00314483

Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease

Evaluation of Potential Mesenchymal Stem Cells for the Treatment of Graft Versus Host Disease Following an Allogeneic Stem Cell Transplant

Sponsor: Christian Medical College, Vellore, India

Conditions Graft vs Host Disease

Interventions Mesenchymal Stem Cell Infusion

Updated 5 times since 2017 Last updated: Jul 3, 2007 Started: Jun 30, 2007 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00314483, this PHASE1/PHASE2 trial focuses on Graft vs Host Disease and remains ongoing. Sponsored by Christian Medical College, Vellore, India, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Christian Medical College, Vellore, India

Data source: Christian Medical College, Vellore, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vellore, India